Superwarfarins represent a class of long‐acting anticoagulant rodenticides that exert their effect through profound inhibition of vitamin K recycling, primarily by targeting vitamin K epoxide ...

The Heparin market is experiencing significant growth due to the rising prevalence of venous thromboembolism (VTE) and blood clotting disorders. VTE includes deep vein thrombosis and pulmonary ...

Patients with cancer are more likely to die from cardiovascular diseases, according to a study.The study, published in the ...

Patients diagnosed with cancer are at a higher risk of dying from cardiovascular diseases (CVD), according to a new study ...

For men with hemophilia B, receipt of gene therapy comprising an infusion of etranacogene dezaparvovec results in sustained endogenous factor IX expression and low annualized bleeding rates over five ...

Abstract Platelets and blood-clotting factors are critical for haemostasis, which is the prevention of unwanted blood loss, usually following injury or trauma. Coagulopathies can manifest as either ...

A pooled plasma (human) blood product for the replacement of clotting proteins (coagulation factors) in certain medical conditions where patients have insufficient levels has been approved for use in ...

Dublin, July 24, 2025 (GLOBE NEWSWIRE) -- The "Coagulation Factor Deficiency Market - A Global and Regional Analysis: Focus on Deficiency Type, Product Type, End-User, and Region - Analysis and ...

Thousands of young women who experience heavy periods are unknowingly suffering from a genetic disorder that puts them at high risk of life-threatening complications during childbirth. Conditions that ...

poses a challenge. Key market players include Aspen Pharmacare Holdings Ltd, B.Braun SE, Baxter International Inc., Dr Reddys Laboratories Ltd., Eisai Co. Ltd ...